Tom Schwarz
Angel Investor
Bilthoven, The Netherlands
Tom Schwarz is a startup investor in Bilthoven. Tom Schwarz, partner, possesses seed and early stage investment and corporate experience. Tom was co-founder, general partner of Life Sciences Partners, a biotech venture capital fund with offices in Amsterdam, Munich and Boston, where he focused on early stage investments in the Benelux. Tom has served on the supervisory boards of many biotechcompanies and is a board member for Biopartner Start-up Ventures, and a former member of the EVCA High Tech Committee. In 1997, Tom sold U-Gene Research, a company he spun-out of the University of Utrecht, to Kendle, a leading US clinical research organization. Tom started his career at Interpharm, one of the largest pharmaceutical wholesalers in the Netherlands. He was trained as a pharmacist at the University of Utrecht.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Tom Schwarz?
Public channels for Tom Schwarz include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
